Filter by
Our projects (109)
RSSShowing results 60 to 80
Using genomics to track mpox Building on the existing Global Health EDCTP3-funded ODIN project, the ODIN-Mpox project is applying genomic technologies to wastewater surveillance to track the...
Rapid detection of Ebola virus infectionsThe EPoCA project is developing an innovative new point-of-care test for Ebola virus infections that will also give insights into infection severity...
Oversight of molecular and cellular therapiesThe CAPACITY 2023 project is strengthening capacity for ethics review and regulatory oversight of clinical research projects involving gene...
Training new African ‘bioentrepreneurs’The SAHRI Fellowship project provides promising researchers from sub-Saharan Africa with a structured three-year training programme that includes a 6...
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...
Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more...
Our overall objective is to integrate our consortium’s individual skills, capacity and innovations into advanced, low-cost and deployable digital dashboards and diagnostics to understand how...
Mitigating the risk of antimalarial resistanceThe MARC-SE Africa project is enabling key countries in Africa to track and respond to rising rates of resistance to antimalarial drugs.
Widening genomic surveillance in Southern and Eastern AfricaThe GenPath Africa project is expanding existing genomic surveillance infrastructure to capture information on drug-resistant...
Advancing malaria treatments for pregnant womenAdditional Global Health EDCTP3 funding is completing the evaluation of a new antimalarial treatment for pregnant women.
Amplifying access to new antibioticsThe ComBac-Africa project is working to improve access to new antibiotics in sub-Saharan Africa, incorporating measures to ensure their judicious use and...
Simplifying treatment of neglected skin diseasesThe TEBULA project is advancing a potentially revolutionary new treatment for two neglected mycobacterial diseases: leprosy and Buruli ulcer.
Community-based care for vulnerable children after hospital dischargeThe SDx project is assessing whether digital tools can enable community health workers to maintain contact with...
Building ethics review and regulatory capacity in East AfricaThe ACCESSAFRICA2 project is strengthening ethics review and regulatory capacity in Ethiopia and Uganda.